awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33439342-79D93ACE-E734-40A8-BD61-92D4DB914BA0
Q33439342-79D93ACE-E734-40A8-BD61-92D4DB914BA0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33439342-79D93ACE-E734-40A8-BD61-92D4DB914BA0
A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients.
P2860
Q33439342-79D93ACE-E734-40A8-BD61-92D4DB914BA0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33439342-79D93ACE-E734-40A8-BD61-92D4DB914BA0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e65d3a09a8cbe21d4ce84c82da2062caa1b5707d
P2860
Phase I dose-escalation trial of checkpoint kinase 1 inhibitor MK-8776 as monotherapy and in combination with gemcitabine in patients with advanced solid tumors.